Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-31 @ 3:54 PM
Study NCT ID:
NCT04936594
Status:
COMPLETED
Last Update Posted:
2023-07-13
First Post:
2021-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'submissionTracking': {'firstMcpInfo': {'postDateStruct': {'date': '2023-05-06', 'type': 'ACTUAL'}}}}, 'conditionBrowseModule': {'meshes': [{'id': 'D016540', 'term': 'Smoking Cessation'}], 'ancestors': [{'id': 'D015438', 'term': 'Health Behavior'}, {'id': 'D001519', 'term': 'Behavior'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D050781', 'term': 'Transcranial Magnetic Stimulation'}], 'ancestors': [{'id': 'D055909', 'term': 'Magnetic Field Therapy'}, {'id': 'D013812', 'term': 'Therapeutics'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'gopalkumar.rakesh@uky.edu', 'phone': '859-562-2348', 'title': 'Dr. Gopalkumar Rakesh', 'organization': 'University of Kentucky'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'timeFrame': '4 weeks after intervention', 'eventGroups': [{'id': 'EG000', 'title': 'People Living With HIV/AIDS (PLWHA) Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).', 'otherNumAtRisk': 8, 'deathsNumAtRisk': 8, 'otherNumAffected': 0, 'seriousNumAtRisk': 8, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Change in Attentional Bias iTBS (Intermittent Theta Burst Stimulation) Smoking', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'People Living With HIV/AIDS (PLWHA) Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '1007.05', 'spread': '148.70', 'groupId': 'OG000'}]}]}, {'title': 'After Intervention', 'categories': [{'measurements': [{'value': '566.89', 'spread': '121.70', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing People Smoking Cigarettes. Measured after iTBS using visual probe task administered (adapted for smoking images) on a computer and eye tracker. Images of smoking and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds', 'unitOfMeasure': 'milliseconds', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Change in Attentional Bias Sham Smoking', 'denoms': [{'units': 'Participants', 'counts': [{'value': '5', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'People Living With HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '884.60', 'spread': '112.77', 'groupId': 'OG000'}]}]}, {'title': 'After Intervention', 'categories': [{'measurements': [{'value': '658.67', 'spread': '148.63', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing People Smoking Cigarettes. Measured after sham using visual probe task (adapted for smoking images) administered on a computer and eye tracker. Images of smoking and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds', 'unitOfMeasure': 'milliseconds', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': '3 participants who got itbs did not show up for the sham visit'}, {'type': 'PRIMARY', 'title': 'Change in Attentional Bias iTBS Paraphernalia', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'People Living With HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).\n\niTBS: 1800 pulses of iTBS\n\nTMS: MagVenture MagPro x100 device. This will be used as the comparator.'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '670.43', 'spread': '139.26', 'groupId': 'OG000'}]}]}, {'title': 'After Intervention', 'categories': [{'measurements': [{'value': '443.10', 'spread': '136.37', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing Cigarette Paraphernalia. Measured after iTBS using visual probe task (adapted for smoking images) administered on a computer and eye tracker. Images of cigarette paraphernalia and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds', 'unitOfMeasure': 'milliseconds', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Change in Attentional Bias Sham Paraphernalia', 'denoms': [{'units': 'Participants', 'counts': [{'value': '5', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'People Living With HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).\n\niTBS: 1800 pulses of iTBS\n\nTMS: MagVenture MagPro x100 device. This will be used as the comparator.'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '528.38', 'spread': '139.39', 'groupId': 'OG000'}]}]}, {'title': 'After Intervention', 'categories': [{'measurements': [{'value': '307.56', 'spread': '135.26', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing Cigarette Paraphernalia. Measured after sham using visual probe task (adapted for smoking images) administered on a computer and eye tracker. Images of cigarette paraphernalia and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds', 'unitOfMeasure': 'milliseconds', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': '3 participants who got itbs did not show up for the sham visit'}, {'type': 'SECONDARY', 'title': 'Change in Tobacco Craving Questionnaire Short Form (TCQ-SF) iTBS', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'People Living With HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '55.88', 'spread': '3.95', 'groupId': 'OG000'}]}]}, {'title': 'After Intervention', 'categories': [{'measurements': [{'value': '43.13', 'spread': '4.68', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Craving measured using TCQ-SF. The Tobacco Craving Questionnaire-short form (TCQ-SF) consists of 12 items rated on a visual analogue scale from 0 to 84 with a higher score equating to increased craving.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Change in Tobacco Craving Questionnaire Short Form (TCQ-SF) Sham', 'denoms': [{'units': 'Participants', 'counts': [{'value': '5', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'People Living With HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '53.2', 'spread': '4.77', 'groupId': 'OG000'}]}]}, {'title': 'After Intervention', 'categories': [{'measurements': [{'value': '48.40', 'spread': '6.84', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Craving measured using TCQ-SF. The Tobacco Craving Questionnaire-short form (TCQ-SF) consists of 12 items rated on a visual analogue scale from 0 to 84 with a higher score equating to increased craving.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants completed the iTBS session but 3 participants did not show up for the sham visit'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Resting State Functional Connectiivity', 'timeFrame': 'Baseline', 'description': 'Measured in MRI scanner', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Resting State Functional Connectiivity', 'timeFrame': 'Four hours from baseline', 'description': 'Measured in MRI scanner', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'People Living With HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS (Intermittent Theta Burst Stimulation) and a sham comparator (TMS).'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '8'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '8'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}]}]}], 'preAssignmentDetails': 'A total of 9 participants were enrolled; however, 1 participant dropped out before the experimental sessions began.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}]}], 'groups': [{'id': 'BG000', 'title': 'People Living With HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '42.88', 'spread': '3.45', 'groupId': 'BG000'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '1', 'groupId': 'BG000'}]}, {'title': 'Male', 'measurements': [{'value': '7', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}]}, {'title': 'Black or African American', 'measurements': [{'value': '3', 'groupId': 'BG000'}]}, {'title': 'White', 'measurements': [{'value': '5', 'groupId': 'BG000'}]}, {'title': 'More than one race', 'measurements': [{'value': '0', 'groupId': 'BG000'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'United States', 'categories': [{'measurements': [{'value': '8', 'groupId': 'BG000'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2023-02-07', 'size': 20831559, 'label': 'Study Protocol, Statistical Analysis Plan, and Informed Consent Form', 'hasIcf': True, 'hasSap': True, 'filename': 'Prot_SAP_ICF_000.pdf', 'typeAbbrev': 'Prot_SAP_ICF', 'uploadDate': '2023-04-04T10:43', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE', 'maskingDescription': 'All participants received iTBS (intermittent theta burst stimulation) first and sham subsequently but were blinded regarding treatment.'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'Single blind within participant design'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 9}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-05-24', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-06', 'completionDateStruct': {'date': '2021-11-24', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-06-22', 'studyFirstSubmitDate': '2021-06-02', 'resultsFirstSubmitDate': '2023-04-10', 'studyFirstSubmitQcDate': '2021-06-15', 'lastUpdatePostDateStruct': {'date': '2023-07-13', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2023-06-22', 'studyFirstPostDateStruct': {'date': '2021-06-23', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2023-07-13', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2021-11-24', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'Resting State Functional Connectiivity', 'timeFrame': 'Baseline', 'description': 'Measured in MRI scanner'}, {'measure': 'Resting State Functional Connectiivity', 'timeFrame': 'Four hours from baseline', 'description': 'Measured in MRI scanner'}], 'primaryOutcomes': [{'measure': 'Change in Attentional Bias iTBS (Intermittent Theta Burst Stimulation) Smoking', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing People Smoking Cigarettes. Measured after iTBS using visual probe task administered (adapted for smoking images) on a computer and eye tracker. Images of smoking and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds'}, {'measure': 'Change in Attentional Bias Sham Smoking', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing People Smoking Cigarettes. Measured after sham using visual probe task (adapted for smoking images) administered on a computer and eye tracker. Images of smoking and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds'}, {'measure': 'Change in Attentional Bias iTBS Paraphernalia', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing Cigarette Paraphernalia. Measured after iTBS using visual probe task (adapted for smoking images) administered on a computer and eye tracker. Images of cigarette paraphernalia and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds'}, {'measure': 'Change in Attentional Bias Sham Paraphernalia', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Cues Encompassing Cigarette Paraphernalia. Measured after sham using visual probe task (adapted for smoking images) administered on a computer and eye tracker. Images of cigarette paraphernalia and a matched neutral cue were presented on a laptop screen, 3 cm apart. Upon offset of the image pairs, a visual probe (X) appeared on either the left side or right side of the screen, in the same location as one of the previously presented images. Attentional bias is quantified using fixation time on cigarette and neutral cues, via an eye tracker in milliseconds'}], 'secondaryOutcomes': [{'measure': 'Change in Tobacco Craving Questionnaire Short Form (TCQ-SF) iTBS', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Craving measured using TCQ-SF. The Tobacco Craving Questionnaire-short form (TCQ-SF) consists of 12 items rated on a visual analogue scale from 0 to 84 with a higher score equating to increased craving.'}, {'measure': 'Change in Tobacco Craving Questionnaire Short Form (TCQ-SF) Sham', 'timeFrame': 'baseline and immediately after intervention, approximately 4 hours', 'description': 'Craving measured using TCQ-SF. The Tobacco Craving Questionnaire-short form (TCQ-SF) consists of 12 items rated on a visual analogue scale from 0 to 84 with a higher score equating to increased craving.'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': True}, 'conditionsModule': {'keywords': ['Transcranial magnetic stimulation (TMS)', 'Attentional bias', 'Conditioning'], 'conditions': ['Smoking Cessation', 'HIV', 'Craving']}, 'descriptionModule': {'briefSummary': 'The pilot study proposal aims to modulate craving and attentional bias towards smoking cues in 40 people living with HIV/AIDS (PLWHA) using transcranial magnetic stimulation (TMS), with functional MRI (fMRI) brain correlates. TMS is a form of noninvasive brain stimulation and modulates neural activity using tiny doses of focused electricity. For the study, participants would perform two cognitive tasks and neuroimaging before and after the TMS and investigators would compare changes in these paradigms with TMS. The investigators will also get a point of contact urine drug screen before study initiation. The investigators will aim to recruit 20 subjects in each arm of our trial (total of 40) from the BlueGrass HIV Clinic.', 'detailedDescription': 'People living with HIV/AIDS (PLWHA) smoke at nearly three times the rate of the general population. These extraordinary smoking rates are associated with greater AIDS-related cancer, non-AIDS related morbidity including non-AIDS-defining cancer, cardiovascular disease, pulmonary disease, and mortality. Smoking significantly impacts the progression and outcome of HIV disease and has been identified as the leading contributor to premature mortality in PLWHA. Suboptimal results with current smoking cessation strategies makes identifying new adjunct strategies an area of need. The pilot study proposal aims to modulate craving and attentional bias towards smoking cues in people living with HIV/AIDS (PLWHA) using transcranial magnetic stimulation (TMS), with functional MRI (fMRI) brain correlates. TMS is a form of noninvasive brain stimulation and modulates neural activity using tiny doses of focused electricity. The TMS paradigm we would be performing is called theta burst stimulation (TBS), which is potent, short, and efficient. It has shown to cause neuroplasticity even with a single session and was approved by the FDA for treatment of major depressive disorder in 2019.\n\nTargeting the left dorsolateral prefrontal cortex (DLPFC) by using MNI coordinates (-44,40,29) via Brainsight Neuronavigation will modulate craving and attentional bias that is closely associated with craving. For this pilot study, 40 participants will perform the attentional bias task, craving scale and neuroimaging before and after the TBS/ sham TMS session, to compare changes in these paradigms between these interventions. Attentional bias would be measured with eye tracking, craving will be assessed with tobacco craving questionnaire (TCQ-SF). The investigators will aim to recruit 10 subjects from the BlueGrass HIV Clinic, who have an established pipeline for enrolling PLWHA patients in clinical trials. Although there is limited data on TMS in smoking, there have been no TMS studies done in PLWHA'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '60 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients enrolled in the Bluegrass Clinic\n* Confirmed chart diagnosis of a HIV and receiving HIV treatment at the participating HIV clinic\n* Age 18-60 years\n* Preferably right hand dominant\n* Currently self-report smoking 10 of more cigarettes per day or a score of \\> 5 on the Fagerstrom Test for Nicotine\n* Willing and able to abstain from all drug use\n* Exhaled breath on day of study Carbon Monoxide \\< 10 ppm\n* Stabilized on maintenance buprenorphine if having comorbid opioid use disorder\n* Able to read and speak English\n* Able to provide informed consent to participate.\n\nExclusion Criteria:\n\n* Pregnant, nursing, or becoming pregnant during the study\n* History of traumatic brain injury or seizures which are contraindications for transcranial magnetic stimulation (TMS)\n* Increased risk of seizure for any reason, including prior diagnosis of epilepsy, seizure disorder, increased intracranial pressure, or history of significant head trauma with loss of consciousness for ≥ 5 minutes which are all contraindications for TMS\n* Presence of intracranial implants (e.g. aneurysms clips, shunts, stimulators, cochlear implants, or electrodes), cardiac pacemakers, or vagus nerve stimulation device which are all contraindications for magnetic resonance imaging\n* Neurological disorder including, but not limited to: space occupying brain lesion; any history of seizures, history of cerebrovascular accident; fainting, cerebral aneurysm, major neurocognitive disorder, Huntington chorea; multiple sclerosis which are all contraindications for TMS.'}, 'identificationModule': {'nctId': 'NCT04936594', 'briefTitle': 'TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)', 'organization': {'class': 'OTHER', 'fullName': 'University of Kentucky'}, 'officialTitle': 'Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)', 'orgStudyIdInfo': {'id': '64473'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'People Living with HIV/AIDS Who Smoke', 'description': 'Participants will be people living with HIV/AIDS who smoke. They will receive two interventions: iTBS and a sham comparator (TMS).', 'interventionNames': ['Device: iTBS', 'Device: TMS']}], 'interventions': [{'name': 'iTBS', 'type': 'DEVICE', 'otherNames': ['Intermittent theta burst stimulation'], 'description': '1800 pulses of iTBS', 'armGroupLabels': ['People Living with HIV/AIDS Who Smoke']}, {'name': 'TMS', 'type': 'DEVICE', 'otherNames': ['Transcranial magnetic stimulation'], 'description': 'MagVenture MagPro x100 device. This will be used as the comparator.', 'armGroupLabels': ['People Living with HIV/AIDS Who Smoke']}]}, 'contactsLocationsModule': {'locations': [{'zip': '40509', 'city': 'Lexington', 'state': 'Kentucky', 'country': 'United States', 'facility': '245 Fountain Court', 'geoPoint': {'lat': 37.98869, 'lon': -84.47772}}], 'overallOfficials': [{'name': 'Gopalkumar Rakesh, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Assistant Professor, University of Kentucky'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Gopalkumar Rakesh', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR_INVESTIGATOR', 'investigatorTitle': 'Assistant Professor', 'investigatorFullName': 'Gopalkumar Rakesh', 'investigatorAffiliation': 'University of Kentucky'}}}}